melatonin has been researched along with rivastigmine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Finkin-Groner, E; Ginsburg, I; Lerman, L; Nudelman, A; Shalom, H; Weill, T; Weinstock, M; Yanovsky, I; Zaikin, A; Zeeli, S | 1 |
| Hu, Y; Li, Y; Peng, P; Sheng, R; Tang, L | 1 |
| Feng, F; He, S; Jiang, H; Jiang, X; Liu, W; Qu, W; Sun, H; Zhou, J | 1 |
| García-Borreguero, D; Serrano, C | 1 |
| Carvalho, AF; Chen, TY; Chen, YW; Cheng, YS; Hsu, CW; Li, DJ; Liang, CS; Lin, PY; Matsuoka, YJ; Shiue, YL; Stubbs, B; Su, KP; Sun, CK; Tseng, PT; Tu, YK; Wu, YC; Yang, CP; Yeh, PY; Zeng, BY | 1 |
| Majidazar, R; Naseri, A; Rezazadeh-Gavgani, E; Sadigh-Eteghad, S | 1 |
| Avidan, AY; Carandang, G; During, EH; Foldvary-Schaefer, N; Howell, M; Kazmi, U; Malkani, RG; McCarter, SJ; Ramar, K; Roland, JP; Zak, RS | 1 |
5 review(s) available for melatonin and rivastigmine
| Article | Year |
|---|---|
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.
Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands | 2019 |
Fluctuations in cognition and alertness in Parkinson's disease and dementia.
Topics: Awareness; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Double-Blind Method; Humans; Lewy Body Disease; Melatonin; Multicenter Studies as Topic; Parkinson Disease; Phenylcarbamates; Phototherapy; Randomized Controlled Trials as Topic; Rivastigmine | 2004 |
The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.
Topics: Alzheimer Disease; Cognition; Humans; Melatonin; Network Meta-Analysis; Randomized Controlled Trials as Topic; Rivastigmine | 2022 |
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
Topics: Alzheimer Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Glycogen Synthase Kinase 3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indans; Lithium; Melatonin; Memantine; Neurodegenerative Diseases; Rivastigmine; Systematic Reviews as Topic | 2022 |
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United States | 2023 |
2 other study(ies) available for melatonin and rivastigmine
| Article | Year |
|---|---|
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Apoptosis; Carbamates; Chickens; Cholinesterase Inhibitors; Humans; Indoles; Neurons | 2012 |
Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Curcumin; Dose-Response Relationship, Drug; Drug Design; Ligands; Molecular Docking Simulation; Molecular Structure; Phenylcarbamates; Rivastigmine; Structure-Activity Relationship | 2014 |